Lucas Antônio Miranda Ferreira (Lucas A M Ferreira, Lucas Am Ferreira)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Nanomedicine (London, England)

Pharmaceutics

Universidade Federal de Minas Gerais

Université Paris-Sud (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Federal de Minas Gerais Jan 19o 1996

Brazil

Professor/PhD :: Department of Pharmaceutics

Education History

Université Paris-Sud Sep 1o 1990 - Dec 5o 1994

France

PHD :: Department of Pharmaceutics

Publications

Gabriel Silva Marques Borges, Eduardo Burgarelli Lages, Gisele Assis Castro Goulart, Lucas Antônio Miranda Ferreira
Nanoencapsulated all- trans retinoic acid as an adjuvant for mucosal vaccines. Nanomedicine (London, England) (2023)
Eduardo Burgarelli Lages, Gabriel Silva Marques Borges, Lucas Antônio Miranda Ferreira
Novel formulation approaches for synergistic codelivery based on lipid nanocarriers. Nanomedicine (London, England) (2023)
Darline B Dos Santos, Janaina A Lemos, Sued Eustaquio Mendes Miranda, Leonardo D Di Filippo, Jonatas Lobado Duarte, Lucas Antônio Miranda Ferreira, André Luís Branco de Barros, Anna E M F M Oliveira
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment. Pharmaceutics 14 (11) (2022)
Izabela Mansur-Alves, Brenda Lorrayne Furtado Lima, Thais Tunes Santos, Naialy F Araújo, Frédéric Frézard, Arshad Islam, André Luís Branco de Barros, Délia Cm Dos Santos, Christian Fernandes, Lucas Antônio Miranda Ferreira, Marta M G Aguiar
Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis. Nanomedicine (London, England) 17 (18) (2022)
Flávia A Lima, Raquel Virginia Rocha Vilela, Rodrigo L Oréfice, Izabela R Silva, Eduardo Co Reis, Larissa Anastasio Da Costa Carvalho, Silvya Stuchi Maria-Engler, Lucas Antônio Miranda Ferreira, Gisele Assis Castro Goulart
Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers' studies. Nanomedicine (London, England) 16 (16) (2021)
Eduardo Burgarelli Lages, Gabriel Silva Marques Borges, Gisele Assis Castro Goulart, Lucas Antônio Miranda Ferreira
Nanomedicine to deliver docosahexaenoic acid: potential applications to improve health. Nanomedicine (London, England) 16 (18) (2021)
Bruna Rodrigues Dias Assis, Caroline Dohanik da Silva, Marie Gabriele Santiago, Lucas Antônio Miranda Ferreira, Gisele Assis Castro Goulart
Nanotechnology in adjuvants and vaccine development: what should we know? Nanomedicine (London, England) 16 (29) (2021)
Gabriel Silva Marques Borges, Micael de Oliveira Ferencs, Cristina de Mello Gomide Loures, Mostafa Al Abdel-Salam, Fernanda Cristina Gontijo Evangelista, Camila Campos Sales, Pedro Henrique Reis da Silva, Renata Barbosa de Oliveira, Ângelo Malachias, Maria Irene Yoshida, Elaine Maria de Souza-Fagundes, Adriano de Paula Sabino, Christian Fernandes, Lucas Antônio Miranda Ferreira
Novel self-nanoemulsifying drug-delivery system enhances antileukemic properties of all-trans retinoic acid. Nanomedicine (London, England) 15 (15) (2020)

Lucas Antônio Miranda Ferreira.css-eqlu8i{font-size:small;padding-left:4px;} (Lucas A M Ferreira, Lucas Am Ferreira)

Publication Activity (10 Years)

Top Topics

Top Venues

Lucas Antônio Miranda Ferreira (Lucas A M Ferreira, Lucas Am Ferreira)